Showing results (201-210 of 267) with videos related to

Sort By:
Pageof 27
Biochemical and Biophysical Research Communications|April 30, 1992
Isolation of two distinct type I angiotensin II receptor genesT S Elton, C C Stephan, G R Taylor, et al.
HIV Medicine|February 26, 2015
Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJ V Baker, N W Engen, K Huppler Hullsiek, et al.
Annals of Neurology|May 19, 2001
Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosisJ Gieffers, D Pohl, J Treib, et al.
European Urology|February 15, 2001
Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosisM Lein, K Jung, U Elgeti, et al.
HIV Medicine|May 7, 2005
The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral loadM Bickel, V Rickerts, C Stephan, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2009
Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patientsM Bickel, A Bodtländer, G K Knecht, et al.
Der Urologe. Ausg. A|September 25, 2003
[An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l]C Stephan, B Vogel, H Cammann, et al.
International Journal of Cancer|March 10, 2000
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinomaM Lein, K Jung, C Laube, et al.
Breast Cancer Research and Treatment|February 28, 2006
Prediction of breast cancer using volatile biomarkers in the breathMichael Phillips, Renee N Cataneo, Beth Ann Ditkoff, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 12, 2014
Decreased processing speed might account for working memory span deficit in schizophrenia, and might mediate the associations between working memory span and clinical symptomsG Brébion, C Stephan-Otto, E Huerta-Ramos, et al.
Pageof 27